These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 28583049)
1. N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus. Gobira PH; Lima IV; Batista LA; de Oliveira AC; Resstel LB; Wotjak CT; Aguiar DC; Moreira FA J Psychopharmacol; 2017 Jun; 31(6):750-756. PubMed ID: 28583049 [TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant effects of N-arachidonoyl-serotonin, a dual fatty acid amide hydrolase enzyme and transient receptor potential vanilloid type-1 (TRPV1) channel blocker, on experimental seizures: the roles of cannabinoid CB1 receptors and TRPV1 channels. Vilela LR; Medeiros DC; de Oliveira AC; Moraes MF; Moreira FA Basic Clin Pharmacol Toxicol; 2014 Oct; 115(4):330-4. PubMed ID: 24674273 [TBL] [Abstract][Full Text] [Related]
3. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871 [TBL] [Abstract][Full Text] [Related]
4. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction. Laricchiuta D; Centonze D; Petrosini L Behav Brain Res; 2013 Nov; 256():101-7. PubMed ID: 23948212 [TBL] [Abstract][Full Text] [Related]
5. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors. Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090 [TBL] [Abstract][Full Text] [Related]
6. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain. Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920 [TBL] [Abstract][Full Text] [Related]
7. The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice. Costa B; Bettoni I; Petrosino S; Comelli F; Giagnoni G; Di Marzo V Pharmacol Res; 2010 Jun; 61(6):537-46. PubMed ID: 20138997 [TBL] [Abstract][Full Text] [Related]
8. The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats. de Novellis V; Palazzo E; Rossi F; De Petrocellis L; Petrosino S; Guida F; Luongo L; Migliozzi A; Cristino L; Marabese I; Starowicz K; Di Marzo V; Maione S; Neuropharmacology; 2008 Dec; 55(7):1105-13. PubMed ID: 18616956 [TBL] [Abstract][Full Text] [Related]
9. Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT). Bashashati M; Fichna J; Piscitelli F; Capasso R; Izzo AA; Sibaev A; Timmermans JP; Cenac N; Vergnolle N; Di Marzo V; Storr M Neurogastroenterol Motil; 2017 Dec; 29(12):. PubMed ID: 28695708 [TBL] [Abstract][Full Text] [Related]
10. Inhibitions of anandamide transport and FAAH synthesis decrease apoptosis and oxidative stress through inhibition of TRPV1 channel in an in vitro seizure model. Nazıroğlu M; Taner AN; Balbay E; Çiğ B Mol Cell Biochem; 2019 Mar; 453(1-2):143-155. PubMed ID: 30159798 [TBL] [Abstract][Full Text] [Related]
11. Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics. Maione S; Costa B; Piscitelli F; Morera E; De Chiaro M; Comelli F; Boccella S; Guida F; Verde R; Ortar G; Di Marzo V Pharmacol Res; 2013 Oct; 76():98-105. PubMed ID: 23911581 [TBL] [Abstract][Full Text] [Related]
12. TRPV1 modulation of contextual fear memory depends on stimulus intensity and endocannabinoid signalling in the dorsal hippocampus. Iglesias LP; Fernandes HB; de Miranda AS; Perez MM; Faccioli LH; Sorgi CA; Bertoglio LJ; Aguiar DC; Wotjak CT; Moreira FA Neuropharmacology; 2023 Feb; 224():109314. PubMed ID: 36336070 [TBL] [Abstract][Full Text] [Related]
14. The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. Navarria A; Tamburella A; Iannotti FA; Micale V; Camillieri G; Gozzo L; Verde R; Imperatore R; Leggio GM; Drago F; Di Marzo V Pharmacol Res; 2014 Sep; 87():151-9. PubMed ID: 24861565 [TBL] [Abstract][Full Text] [Related]
15. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB Stern CAJ; da Silva TR; Raymundi AM; de Souza CP; Hiroaki-Sato VA; Kato L; Guimarães FS; Andreatini R; Takahashi RN; Bertoglio LJ Neuropharmacology; 2017 Oct; 125():220-230. PubMed ID: 28754373 [TBL] [Abstract][Full Text] [Related]
17. A dual inhibitor of FAAH and TRPV1 channels shows dose-dependent effect on depression-like behaviour in rats. Kirkedal C; Wegener G; Moreira F; Joca SRL; Liebenberg N Acta Neuropsychiatr; 2017 Dec; 29(6):324-329. PubMed ID: 27938441 [TBL] [Abstract][Full Text] [Related]
18. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957 [TBL] [Abstract][Full Text] [Related]
19. Blockade of the endovanilloid receptor, TRPV1, and of the endocannabinoid enzyme, FAAH, within the nucleus accumbens shell elicits anxiolytic-like effects in male rats. Pardo-García TR; Yusif-Rodriguez N; Yudowski G; Maldonado-Vlaar CS Neurosci Lett; 2020 Jul; 732():135023. PubMed ID: 32422166 [TBL] [Abstract][Full Text] [Related]
20. A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis. Malek N; Mrugala M; Makuch W; Kolosowska N; Przewlocka B; Binkowski M; Czaja M; Morera E; Di Marzo V; Starowicz K Pain; 2015 May; 156(5):890-903. PubMed ID: 25719612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]